BRPI0710473A2 - ácidos 4-fenil-tiazol-5-carboxìlicos e amidas de ácido 4-fenil-tiazol-5-carboxìlico como inibidores de plk1 - Google Patents

ácidos 4-fenil-tiazol-5-carboxìlicos e amidas de ácido 4-fenil-tiazol-5-carboxìlico como inibidores de plk1 Download PDF

Info

Publication number
BRPI0710473A2
BRPI0710473A2 BRPI0710473-1A BRPI0710473A BRPI0710473A2 BR PI0710473 A2 BRPI0710473 A2 BR PI0710473A2 BR PI0710473 A BRPI0710473 A BR PI0710473A BR PI0710473 A2 BRPI0710473 A2 BR PI0710473A2
Authority
BR
Brazil
Prior art keywords
carboxylic acid
benzoimidazol
phenyl
formula
dimethoxy
Prior art date
Application number
BRPI0710473-1A
Other languages
English (en)
Portuguese (pt)
Inventor
John Frederick Boylan
Jianping Cai
Nader Fotouhi
Paul Gillespie
Robert Alan Goodnow Jr
Kang Le
Christophe Michoud
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BRPI0710473A2 publication Critical patent/BRPI0710473A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
BRPI0710473-1A 2006-02-27 2007-02-19 ácidos 4-fenil-tiazol-5-carboxìlicos e amidas de ácido 4-fenil-tiazol-5-carboxìlico como inibidores de plk1 BRPI0710473A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77696406P 2006-02-27 2006-02-27
US60/776,964 2006-02-27
PCT/EP2007/051541 WO2007096315A1 (en) 2006-02-27 2007-02-19 4-phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as plk1 inhibitors

Publications (1)

Publication Number Publication Date
BRPI0710473A2 true BRPI0710473A2 (pt) 2011-08-16

Family

ID=38051896

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0710473-1A BRPI0710473A2 (pt) 2006-02-27 2007-02-19 ácidos 4-fenil-tiazol-5-carboxìlicos e amidas de ácido 4-fenil-tiazol-5-carboxìlico como inibidores de plk1

Country Status (19)

Country Link
US (1) US7504513B2 (https=)
EP (1) EP1991543A1 (https=)
JP (1) JP2009528284A (https=)
KR (1) KR101060539B1 (https=)
CN (1) CN101415704A (https=)
AR (1) AR059621A1 (https=)
AU (1) AU2007217575A1 (https=)
BR (1) BRPI0710473A2 (https=)
CA (1) CA2642921A1 (https=)
CR (1) CR10206A (https=)
EC (1) ECSP088700A (https=)
IL (1) IL193481A0 (https=)
MA (1) MA30260B1 (https=)
MX (1) MX2008010884A (https=)
NO (1) NO20083708L (https=)
RU (1) RU2008138163A (https=)
TW (1) TW200745097A (https=)
WO (1) WO2007096315A1 (https=)
ZA (1) ZA200807074B (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5246158B2 (ja) * 2007-06-08 2013-07-24 日本電気株式会社 半導体集積回路及びフィルタ制御方法
JP5581219B2 (ja) 2008-01-25 2014-08-27 ミレニアム ファーマシューティカルズ, インコーポレイテッド チオフェンおよびホスファチジルイノシトール3−キナーゼ(pi3k)阻害薬としてのその使用
KR101707669B1 (ko) * 2008-04-17 2017-02-16 더 존스 홉킨스 유니버시티 약제-내성 종양에서 화학요법제 활성을 증강시키는 on01910.na
EA016789B1 (ru) * 2008-09-10 2012-07-30 Дейталейз Лтд. Среда для хранения данных
WO2010077295A1 (en) * 2008-12-09 2010-07-08 King Faisal Specialist Hospital & Research Centre Substituted tricyclic heterocycles and uses to treat tumors and proliferative disorders
CA2745596A1 (en) 2008-12-18 2010-10-28 F. Hoffmann-La Roche Ag Thiazolyl-benzimidazoles
WO2010090716A1 (en) * 2009-01-30 2010-08-12 Millennium Pharmaceuticals, Inc. Heteroaryls and their use as pi3k inhibitors
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
US9090601B2 (en) * 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
US8859768B2 (en) 2010-08-11 2014-10-14 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2012021611A1 (en) 2010-08-11 2012-02-16 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
MX2013001660A (es) 2010-08-11 2013-06-03 Millenium Pharmaceuticals Inc Heteroarilos y usos de los mismos.
TW201307309A (zh) 2010-10-13 2013-02-16 Millennium Pharm Inc 雜芳基化合物及其用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322429A (en) * 1980-09-16 1982-03-30 Eli Lilly And Company Isoxazolylbenzamides as insecticides
US4818270A (en) * 1986-08-28 1989-04-04 Monsanto Company 2-(Heteroamino)-4,5-substituted-oxazole/thiazole compounds as herbicide antidotes, compositions and use
US6194447B1 (en) * 1998-07-02 2001-02-27 Neurosearch A/S Bis (benzimidazole) derivatives serving as potassium blocking agents
ES2349762T3 (es) 2000-08-10 2011-01-11 Pfizer Italia S.R.L. Biciclo-pirazoles activos como inhibidores de quinasas, procedimientos para su preparación y composiciones farmacéuticas que los comprenden.
GB0102687D0 (en) 2001-02-02 2001-03-21 Pharmacia & Upjohn Spa Oxazolyl-pyrazole derivatives active as kinase inhibitors,process for their preparation and pharmaceutical compositions comprising them
WO2003070283A2 (en) 2002-02-22 2003-08-28 Klaus Strebhardt Agent for inhibiting development or progress of proliferative diseases and especially cancer diseases and pharmaceutical composition containing said agent
EP1486490A1 (en) * 2002-02-28 2004-12-15 Takeda Chemical Industries, Ltd. Azole compounds
JP2003321460A (ja) * 2002-02-28 2003-11-11 Takeda Chem Ind Ltd アゾール化合物
NZ535232A (en) 2002-02-28 2007-05-31 Univ Temple Amino-substituted (E)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders
JP2005538048A (ja) 2002-05-03 2005-12-15 シエーリング アクチエンゲゼルシャフト チアゾリジノン類、それらの生成及び医薬剤としての使用
US6906186B1 (en) 2002-07-30 2005-06-14 Isis Pharmaceuticals, Inc. Antisense modulation of polo-like kinase expression
MXPA05001544A (es) * 2002-08-08 2005-04-19 Smithkline Beecham Corp Compuestos de tiofeno.
AU2003284399A1 (en) 2002-11-14 2004-06-03 Kyowa Hakko Kogyo Co., Ltd. Plk inhibitors
US20050196808A1 (en) 2002-11-14 2005-09-08 Yaffe Michael B. Products and processes for modulating peptide-peptide binding domain interactions
JP3837670B2 (ja) 2002-12-12 2006-10-25 富士通株式会社 データ中継装置、連想メモリデバイス、および連想メモリデバイス利用情報検索方法
GB0302220D0 (en) 2003-01-30 2003-03-05 Cyclacel Ltd Use
ES2325440T3 (es) 2003-02-20 2009-09-04 Smithkline Beecham Corporation Compuestos de pirimidina.
US7462614B2 (en) 2003-04-01 2008-12-09 Smithkline Beecham Corporation Imidazotriazine compounds
DK1641780T3 (da) 2003-06-24 2009-02-02 Pfizer Prod Inc Fremgangsmåder til fremstilling af 1-[(benzimidazol-1yl)quinolin-8-yl]-piperidin-4-ylamin-derivater
WO2005019193A2 (en) 2003-08-20 2005-03-03 Smithkline Beecham Corporation Phenylurea derivatives useful in the treatment of conditions mediated by polo-like kinases (plk)
CA2542880A1 (en) 2003-10-21 2005-05-12 Cyclacel Limited Pyrimidin-4-yl-3, 4-thione compounds and their use in therapy
DE10351744A1 (de) 2003-10-31 2005-06-16 Schering Ag Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel
EP1711496A4 (en) 2004-01-28 2009-02-11 Smithkline Beecham Corp THIAZOLE COMPOUNDS

Also Published As

Publication number Publication date
AU2007217575A1 (en) 2007-08-30
KR101060539B1 (ko) 2011-08-30
CN101415704A (zh) 2009-04-22
CR10206A (es) 2008-09-22
WO2007096315A1 (en) 2007-08-30
ECSP088700A (es) 2008-09-29
CA2642921A1 (en) 2007-08-30
US7504513B2 (en) 2009-03-17
TW200745097A (en) 2007-12-16
NO20083708L (no) 2008-09-23
MX2008010884A (es) 2008-09-03
US20070203210A1 (en) 2007-08-30
EP1991543A1 (en) 2008-11-19
IL193481A0 (en) 2009-05-04
AR059621A1 (es) 2008-04-16
MA30260B1 (fr) 2009-03-02
JP2009528284A (ja) 2009-08-06
ZA200807074B (en) 2009-10-28
RU2008138163A (ru) 2010-04-10
KR20080090550A (ko) 2008-10-08

Similar Documents

Publication Publication Date Title
BRPI0710473A2 (pt) ácidos 4-fenil-tiazol-5-carboxìlicos e amidas de ácido 4-fenil-tiazol-5-carboxìlico como inibidores de plk1
JP4805916B2 (ja) 化合物、組成物、および方法
CA2778115C (en) Imidazole derivatives as ido inhibitors
CN102008459B (zh) 抗菌剂
CN104003940B (zh) 2,4‑二氟‑5‑(酞嗪酮‑1‑甲基)‑苯甲酰哌嗪类化合物及其用途
US5622948A (en) Pyrrole pyridazine and pyridazinone anti-inflammatory agents
US20100069453A1 (en) Certain Chemical Entities, Compositions, and Methods
JP2010507674A (ja) マトリクスメタロプロテアーゼ阻害剤としての三環式化合物
KR102214225B1 (ko) 5원 헤테로시클릭 아미드계 wnt 경로 억제제
WO2012131501A1 (en) Substituted benzimidazole compounds as cot kinase inhibitors
WO2022127199A1 (zh) 一类抑制rna解旋酶dhx33的多环化合物及其应用
CN101404989B (zh) 抗菌剂
CN110234640B (zh) 作为抗癌剂的苯并咪唑衍生物
CN116655538A (zh) 一种淋巴瘤治疗药物中间体的制备方法
RS59787B1 (sr) Novo heterociklično jedinjenje, metoda za pripremu istog, i farmaceutska kompozicija koja sadrži isto
CN114621194B (zh) 一种4-亚甲基-n-羟基苯甲酰胺类化合物及其应用
WO2004099190A1 (en) Novel substituted benzimidazole derivatives
Wang et al. Synthesis and anticancer activity of novel 5-(indole-2-yl)-3-substituted 1, 2, 4-oxadiazoles
AU2020264679B2 (en) Selective ligands of human constitutive androstane receptor
Gaikwad et al. SYNTHESIS OF NOVEL SUBSTITUTED-BENZO [d] THIAZOLE-2, 4-DICARBOXAMIDES HAVING KINASE INHIBITION AND ANTI-PROLIFERATIVE ACTIVITY
JP2009514865A (ja) 有糸分裂キネシン阻害剤
CZ34975U1 (cs) Ligandy lidského konstitutivního adrostanového receptoru
TW202304884A (zh) 經取代之吡咯甲醯胺、其製備方法及其作為激酶抑制劑之用途
Sushil et al. Synthesis and Characterization of Novel Oxadiazole Derivatives of 2-mercaptobenzothiazol-A Green Approach
HK1168106B (en) Imidazole derivatives as ido inhibitors

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 4A E 5A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.